医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(S)-2-羟基-3-甲基丁酸甲酯 | methyl (S)-2-hydroxy-3-methylbutanoate | 24347-63-5 | C6H12O3 |
|
(S)-2-羟基-1-(吡咯烷-1-基)-1-丙酮 | (S)-2-hydroxy-1-(pyrrolidin-1-yl)propan-1-one | 122151-38-6 | C7H13NO2 |
|
(S)-2-甲基吡咯烷 | (S)-2-methylpyrrolidine | 59335-84-1 | C5H11N |
|
(S)-2-溴-Alpha-甲基苯甲醇 | (1S)-1-(2-bromophenyl)ethanol | 114446-55-8 | C8H9BrO |
|
(S)-2-氨基辛二酸 | L-2-aminosuberic acid | 4254-88-0 | C8H15NO4 |
|
(S)-2-氨基-5-甲氧基四氢萘盐酸盐 | (S)-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride | 58349-17-0 | C11H15NO*ClH |
|
(S)-2-氨基-4-甲基-1-((R)-2-甲基环氧乙烷-2-基)-1-戊酮三氟乙酸盐 | (2S)-2-amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone trifluoroacetate | 247068-85-5 | C2HF3O2*C9H17NO2 |
|
(S)-2-氨基-3-喹啉-2-丙酸 | (S)-(+)-2-amino-3-(2'-quinolyl)propionic acid | 161513-46-8 | C12H12N2O2 |
|
(S)-2-哌嗪甲醇二盐酸盐 | (S)-Piperazin-2-ylmethanol dihydrochloride | 149629-73-2 | C5H14Cl2N2O |
|
(S)-2-二甲基氨基-1-苯基乙醇 | (S)-2-dimethylamino-1-phenylethanol | 2202-68-8 | C10H15NO |
|
(S)-2-乙基丁基2-氨基丙酸酯盐酸盐 | L-alanine 2-ethylbutyl ester hydrochloride | 946511-97-3 | C9H19NO2*ClH |
|
(S)-2-三氟甲基-哌嗪 | (2S)-2-(trifluoromethyl)piperazine | 1187931-35-6 | C5H9F3N2 |
|
(S)-2-[5-(4-溴苯基)-1H-咪唑-2-基]吡咯烷-1-羧酸叔丁酯 | (S)-tert-butyl 2-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate | 1007882-04-3 | C18H22BrN3O2 |
|
(S)-2-[(4-氯苯基)(4-哌啶氧基)甲基]吡啶 | (S)-(-)-4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidine | 201594-84-5 | C17H19ClN2O |
|
(S)-2-(苄氧基)-1-(吡咯烷-1-基)丙烷-1-酮 | (S)-2-(benzyloxy)-1-(pyrrolidin-1-yl)propan-1-one | 122151-32-0 | C14H19NO2 |
|
(S)-2-(丁-3-烯基)环氧乙烷 | (S)-1,2-epoxy-5-hexene | 137688-21-2 | C6H10O |
|
(S)-2-(n-boc-氨基)-n-苄氧基-3-羟基-3-甲基丁酰胺 | (S)-tert-butyl 1-(benzyloxyamino)-3-hydroxy-3-methyl-1-oxobutan-2-ylcarbamate | 102507-19-7 | C17H26N2O5 |
|
(S)-2-(3,5-二甲基苯基)吡咯烷 | (2S)-2-(3,5-dimethylphenyl)pyrrolidine | 1213334-10-1 | C12H17N |
|
(S)-2-(1,3-二氧代-1,3-二氢异吲哚-2-基)戊二酸-5-苄酯 | (2S)-4-benzyloxicarbonyl-2-phthalimidobutanoic acid | 88784-33-2 | C20H17NO6 |
|
(S)-2-((S)-2-(((((9H-芴-9-基)甲氧基)羰基)氨基)-3-甲基丁酰氨基 | (S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido)-5-ureidopentanoic acid | 159858-21-6 | C26H32N4O6 |
|
(S)-2-((3-氯吡嗪-2-基)甲基氨基甲酰)吡咯烷-1-羧酸苄酯 | (S)-benzyl 2-((3-chloropyrazin-2-yl)methylcarbamoyl)pyrrolidine-1-carboxylate | 1418307-17-1 | C18H19ClN4O3 |
|
(S)-2-((((9h-芴-9-基)甲氧基)羰基)氨基)-6-(((4-甲氧基苯基)二苯基甲基)氨基)己酸 | Fmoc-Lys(Mmt)-OH | 159857-60-0 | C41H40N2O5 |
|
(S)-2,5-二氢-3,6-二甲氧基-2-异丙基吡嗪 | (S)-2-isopropyl-3,6-dimethoxy-2,5-dihydropyrazine | 78342-42-4 | C9H16N2O2 |
|
(S)-2,4-二氯-A-甲基-苯甲胺盐酸盐 | 2,6-dichlorophenylethylamine | 133492-69-0 | C8H9Cl2N |
|
(S)-2,3,4,9-四氢-1H-吡啶[3,4-b]吲哚-3-羧酸 | 3-carboxy-1,2,3,4-tetrahydro-2-carboline | 42438-90-4 | C12H12N2O2 |
|
(S)-1-苯基-1,2,3,4-四氢异喹啉 | (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline | 118864-75-8 | C15H15N |
|
(S)-1-苄氧羰基六氢哒嗪-3-羧酸 | (3S)-hexahydro-1,3-pridazinedicarboxylic acid 1-(phenylmethyl) ester | 65632-62-4 | C13H16N2O4 |
|
(S)-1-苄基-5-氧吡咯烷-3-羧酸 | (S)-(+)-1-(phenylmethyl)-5-oxo-3-pyrrolidinecarboxylic acid | 428518-42-7 | C12H13NO3 |
|
(S)-1-甲基-1,2,3,4-四氢异喹啉 | (-)-1-methyl-1,2,3,4-tetrahydro-isoquinoline | 4965-09-7 | C10H13N |
|
(S)-1-氨基-2,3-二氢-1H-茚-4-腈盐酸盐 | (S)-1-amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride | 1306763-57-4 | C10H10N2*ClH |
|
(S)-1-对甲苯磺酰基-3-(1-氰基-1,1-二苯甲基)吡咯烷 | (S)-2,2-diphenyl-2-(1-tosyl-3-pyrrolidinyl)acetonitrile | 133099-09-9 | C25H24N2O2S |
|
(S)-1-叔丁氧羰基-3-羟基哌啶 | tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate | 143900-44-1 | C10H19NO3 |
|
(S)-1-[3,5-二(三氟甲基)苯基]乙醇 | (S)-3,5-bis(trifluoromethyl)-1-phenylethanol | 225920-05-8 | C10H8F6O |
|
(S)-1-N-Boc-3-氰基哌啶 | (S)-3-cyano-piperidine-1-carboxylic acid tert-butyl ester | 915226-39-0 | C11H18N2O2 |
|
(S)-1-N-Boc-2-甲基哌嗪 | (S)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester | 169447-70-5 | C10H20N2O2 |
|
(S)-1-N-BOC-3-哌嗪甲酸甲酯 | 1-(tert-butyl) 3-methyl (S)-piperazine-1,3-dicarboxylate | 314741-39-4 | C11H20N2O4 |
|
(S)-1-Boc-吡咯烷-3-甲酸 | (S)-1-N-boc-β-proline | 140148-70-5 | C10H17NO4 |
|
(S)-1-Boc-3-羟甲基吡咯烷 | tert-butyl (3S)-3-(hydroxymethyl)pyrrolidine-1-carboxylate | 199174-24-8 | C10H19NO3 |
|
(S)-1-Boc-3-氰基吡咯烷 | tert-butyl (S)-3-cyanopyrrolidine-1-carboxylate | 132945-78-9 | C10H16N2O2 |
|
(S)-1-Boc-3-((二甲基氨基)甲基)吡咯烷 | (S)-1-(t-butoxycarbonyl)-3-(dimethylaminomethyl)pyrrolidine | 859213-51-7 | C12H24N2O2 |
|
(S)-1-Boc-2-异丙基哌嗪 | (S)-tert-butyl 2-isopropylpiperazine-1-carboxylate | 674792-05-3 | C12H24N2O2 |
|
(S)-1-BOC-2-羟甲基哌嗪 | (S)-1-boc-2-hydroxymethylpiperazine | 1030377-21-9 | C10H20N2O3 |
|
(S)-1-(吡啶-2-基)乙醇 | (1S)-1-(2-pyridyl)ethanol | 59042-90-9 | C7H9NO |
|
(S)-1-(5-苯基-1H-咪唑-2-基)乙胺 | (S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine | 864825-23-0 | C11H13N3 |
|
(S)-1-(3-甲氧基苯基)乙胺盐酸盐 | (S)-1-(3-methoxyphenyl)ethylammonium chloride | 1304771-27-4 | C9H13NO*ClH |
|
(S)-1-(3-吡啶基)乙醇 | (S)-1-(3-Pyridyl)ethanol | 5096-11-7 | C7H9NO |
|
(S)-1-(3,5-二氯吡啶-4-取代)乙醇 | (1S)-1-(3,5-dichloro-4-pyridyl)ethanol | 1370347-50-4 | C7H7Cl2NO |
|
(S)-1-(2,6-二氯-3-氟苯基)乙醇 | (S)-1-(2,6-dichloro-3-fluorophenyl)ethan-1-ol | 877397-65-4 | C8H7Cl2FO |
|
(S)-1,4-n-二boc-2-哌嗪-2-羧酸 | (S)-1,4-bis(tert-butoxycarbonyl)piperazine-2-carboxylic acid | 788799-69-9 | C15H26N2O6 |
|
(S)-1,2-双(叔丁氧基羰基)六氢哒嗪-3-羧酸 | (3S)-1,2-bis(tert-butoxycarbonyl)-1,2-diazinane-3-carboxylic acid | 156699-39-7 | C15H26N2O6 |
|